Avenue Therapeutics Inc (NASDAQ:ATXI)

0.6875
BATS BZX Real-Time Price
As of 12:45pm ET
 -0.013 / -1.86%
Today’s Change
0.54
Today|||52-Week Range
16.65
-40.73%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Avenue Therapeutics Inc have a median target of 32.00, with a high estimate of 32.00 and a low estimate of 32.00. The median estimate represents a +4,554.55% increase from the last price of 0.69.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Avenue Therapeutics Inc. This rating has held steady since March, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$0.00
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.77%
 
 
 
 
 
 
Growthannually 0.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.